Photodynamic therapy (PDT) requires photosensitizer, light, and oxygen to induce cell death. The majority of efforts to advance PDT focus only on the first two components. Here, we employ perfluorocarbon nanoemulsions to simultaneously deliver oxygen and photosensitizer. We find that the implementation of fluorous soluble photosensitizers enhances the efficacy of PDT.
1
Current clinical uses of PDT include treatment of actinic keratosis, small cell carcinoma, pleural mesothelioma, oesophageal, nonsmall cell lung and skin cancer with other applications on the horizon as new photosensitizers and endoscopic technologies are developed.
2 Photosensitizer optimization and expanding the scope of tissue that can be irradiated with light contribute to the majority of advancements in PDT. 3 These are critical components; however, the direct therapeutic effect of PDT is a result of ROS such as singlet oxygen ( 1 O 2 ). 4 Hypoxia is a hallmark of many tumors 5 and limits the amount of ROS that can be generated even if ample light and photosensitizer are present. The ideal therapeutic for PDT is one that simultaneously delivers oxygen and photosensitizer to the disease site. Perfluorocarbon (PFC) nanoemulsions, droplets of fluorous solvent stabilized by a surfactant, are a compelling platform for PDT owing to the high oxygen content in perfluorocarbons ( Figure  1B) . 6 Previously, we have shown that fluorophores can be localized inside PFC nanoemulsions when fluorous chains are appended to the chromophore scaffold. 7 We imagined that a similar strategy could be employed to load PFC nanoemulsions with a photosensitizer to result in an exceptional nanomaterial for PDT ( Figure 1C ). Efforts to enhance PDT with perfluorocarbons began in 1988 when Henderson and co-workers co-injected a porphyrin photosensitizer with PFC nanoemulsions. 8 Despite promising results, this approach remained dormant for 25 years until cyanine dyes were embedded into the surfactant layer of PFC nanoemulsions to facilitate dual oxygen and photosensitizer delivery. 9 Contemporary variants of co-administration of photosensitizer and PFC nanoemulsions have also been pursued. Collectively, these reports demonstrate the potential of PFC nanoemulsions for PDT. However, organic photosensitizers are not compatible with the fluorous solvent, which can lead to inefficient photosensitization and leaching. Here, we establish that the use of a fluorous soluble photosensitizer localized within PFC nanoemulsions enhances the efficacy of PDT.
To probe the influence of fluorous soluble photosensitizers on PFC nanoemulsion-based PDT, we prepared fluorous porphyrin 1 along with a control hydrocarbon analogue 2 ( Figure 2A ). 11 Photophysical characterization of 1 and 2 in dimethylformamide and acetone indicates that the absorption, emission, and oxygen sensitization of the porphyrins are minimally altered by the fluorous or alkyl chain appendages ( Figure 2B ). Next, we tested the solubility of 1 and 2 in numerous fluorous and organic solvents, and thoroughly investigated their photophysics in hexanes (HEX) and perfluorohexanes (PFH) as model solvents for each phase ( Figure 2C ). Fluorous porphyrin 1 can be solubilized in both HEX and PFH, as evidenced by robust absorption and emission in each solvent. Distinctly different results are obtained with 2, which is soluble in HEX but not PFH. We further explored the aggregation of 2 in the presence of fluorous solvent and found that a significant decrease in absorption and emission begins in solutions containing greater than 50% fluorous solvent. Aggregation is a common occurrence with chromophores that leads to low quantum yields of emission (Φ F ) and oxygen sensitization (ΦΔ). 12 Thus, these data suggest that when organic photosensitizers are employed in PFC nanoemulsions, aggregation will decrease the efficiency of The most striking data observed in the photophysical characterization of 1 and 2 is the superior production of 1 O 2 with fluorous photosensitizer 1 in PFH ( Figure 2C ), assayed via the direct detection of 1 O 2 phosphorescence at 1274 nm. 13 These data are attributed to the high oxygen content in PFH relative to HEX (4.23 vs. 1.99 mM), 14 the long half-life of 1 O 2 in perfluorocarbons 15 as well as the ability for 1 to readily come into contact with O 2 . Oxygen sensitization is a Dexter-type energy transfer which requires the two species to be within 10-20 Å of eachother. 16 Therefore, solubilizing O 2 and photosensitizer in the same phase should lead to enhanced ΦΔ. Efficient sensitization of oxygen in perfluorocarbons has been observed in synthetic chemistry 17 and is also supported by PDT with surfaces 18 and polymer micelles 19 containing fluorous segments and photosensitizers. With positive initial photophysical characterization of 1 and 2, we prepared PFC and oil emulsions containing each photosensitizer ( Figure 3A , emulsions A-D). PFC nanoemulsions were prepared with a mixture of 7:3 perfluorodecalin (PFD)/ perfluorotripropylamine (PFTPA) ‡ (10 vol%) stabilized by Pluronic F-68 (2.8 wt%) in phosphate buffered saline (PBS) to result in 175 nm emulsions with a polydispersity of 0.08 ( Figure 3B ). Oil emulsions were prepared with olive oil (10 vol%) and Pluronic F-68 (2.8 wt%) in PBS to yield 175 nm emulsions with a polydispersity of 0.15 ( Figure 3C ). We assayed the emulsions and all components for stability to 1 O 2 and did not observe any significant 1 O 2 -induced degradation of the components or instability of the emulsions. Next, we investigated the ability of emulsions A-D to deliver 1 O 2 to the surrounding aqueous media. For these studies, we employed water-soluble, fluorescent anthracene 3, which undergoes a Diels-Alder reaction with 1 O 2 to produce nonemissive adduct 4 ( Figure 3D ). 20 Mixtures of 3 and emulsions A-D in PBS were irradiated with 420 nm light (8.5 mW/cm 2 ), and their photoluminescence was monitored over time. The data show ( Figure 3E ) that the PFC nanoemulsion containing 1 (emulsion A) delivers the most 1 O 2 to the surrounding environment, with the oil emulsions (emulsions C,D) and the PFC nanoemulsion containing 2 (emulsion B) displaying similar, lower levels of 1 O 2 production. In contrast to the photophysical characterization of 2 in PFH, we found that some 2 could be incorporated into PFC emulsions. This result is likely due to interactions between 2 and the Pluronic F-68 surfactant. Similar interactions have enabled the preparation of cyanine-dye loaded PFC nanoemulsions for PDT. 9 We suspected that 2 within emulsion B would readily leach into surrounding lipophilic media, while 1 would be retained inside the PFC nanoemulsions. Leaching and premature drug release are significant problems in nanomedicine and should be considered alongside efficacy when evaluating new therapeutic materials. 21 To demonstrate that the use of a fluorous soluble photosensitizer also enhances the stability of the nanomaterial, we continuously partitioned aqueous suspensions of emulsions A-D with 1-octanol, a lipid bilayer mimic. 22 We monitored the photoluminescence of the 1-octanol over time ( Figure 3F ) and found that 2 was rapidly released from the PFC nanoemulsions (emulsion B) while 1 showed minimal leaching from emulsion A over 7 days ( Figure 3G ). The oil emulsions C and D were also subjected to these conditions and 2 (emulsion D) showed better retention than 1 (emulsion C). These data indicate that the solubility match is important for photosensitizer stabilization within either PFC or oil emulsions. Notably, the core structure of both emulsions appeared stable in these studies. Taken together, these in vitro results suggest PFC nanoemulsions containing fluorous soluble photosensitizers will be superior agents for PDT due to their enhanced oxygen sensitization capabilities and the minimal leaching of the fluorous porphryin to surrounding hydrophilic or lipophilic environments. Following promising characterization, we proceeded to assay the efficacy of PDT with the photosensitizer-containing emulsions in cellulo. In order to visualize the PFC nanoemulsions, emulsion E was prepared which contained fluorous rhodamine 5 7 along with porphyrin 1 (Figures 4A,B) . Emulsion E was readily accessed by pre-dissolving both 1 and 5 in PFD/PFTPA prior to sonication, showcasing the modularity of PFC nanoemulsions for nanomedicine. 23 We subjected emulsion E (1 = 30 µM; 5 = 0.57 mM) to human embryonic kidney (HEK) cells for 3 hours. Confocal microscopy visualizing rhodamine 5 established that the emulsions were internalized ( Figure 4C ). The viability of these cells was verified by NucGreen TM , a cell-death marker 24 ( Figure 4D ).
Upon irradiation with light (420 nm, 8.5 mW/cm 2 , 30 min), cell death was observed as indicated by the NucGreen TM fluorescence and the loss of cell adherence ( Figures 4E ). An analogous experiment was performed with emulsions containing only 5 and showed minimal cell death upon irradiation.
The microscopy studies illustrated that emulsion E was performing as expected, and we proceeded to a flow cytometry assay for further optimization and analysis. Dose-dependent experiments revealed that the efficacy of PDT plateaued at a 1:3 dilution of emulsion A containing 30 µM 1 in the PFD/PFTPA. We employed these conditions to perform a comparative study of the PFC and oil emulsions containing no porphyrin, 1, or 2. HEK cells were incubated with the requisite emulsions or media alone, washed, and treated with light (420 nm, 8.5 mW/cm 2 ) for 0, 10, Figure 3E ) and confirm that the use of fluorous soluble photosensitizers is the most promising avenue for PDT with PFC nanoemulsions.
In summary, we have demonstrated that fluorous photosensitizers sequestered inside PFC nanoemulsions allow the simultaneous delivery of oxygen and photosensitizer to cells. Upon irradiation, the photosensitizer can efficiently produce 1 O 2 due to its minimally aggregated state and close proximity to the solubilized oxygen in the fluorous solvent. Furthermore, the addition of fluorous tags minimizes leaching of the photosensitizer from the PFC nanoemulsions. Efforts are underway to bathochromically-shift the photosensitizer 2b and install biocompatible branched fluorous chains 25 such that the results of this proof-of-concept study can be translated in vivo.
